Are health professionals ready for direct-to-consumer genetic and genomic testing?. (September 2013)

• Record Type: Journal Article
• Authors: Skirton, Heather; Jackson, Leigh; Goldsmith, Lesley; O'Connor, Anita
• Is Part Of: Personalized medicine. Volume 10:Number 7(Year 2013)
• Page Start: 673
• Page End: 682
• Publication Date: 2013-09
• Subjects: direct-to-consumer genetic test -- noninvasive prenatal diagnosis -- professional competence -- professional education -- susceptibility testing; Pharmacogenomics -- Periodicals; Pharmacogenetics -- Periodicals; 615.19
• DOI: 10.2217/pme.13.71
• Languages: English
• ISSNs: 1741-0541

Abstract

Direct-to-consumer genetic and genomic tests have been offered for over a decade. With the reduction in the cost of sequencing, the options for consumers will increase, with subsequent pressure on health services to interpret data and integrate the results into healthcare management. However, indications are that health professionals are grossly unprepared to deal with requests for support from those who have undertaken direct-to-consumer genetic or genomic tests. While benefits may be derived from patient-driven investigations, distinction needs to be made between the mostly uncertain clinical utility of susceptibility testing and the potential benefits of a reliably interpreted sequencing result. It is essential that we develop strategies, including enhanced professional education, to cope with the potential impact on the health services, rather than ignoring these developments. There may also be implications for the future of genetic counseling, with potential changes in the current paradigm.